by Jovana Drinjakovic | Oct 6, 2016
In case you haven’t heard, Tina Gorjanc, a UK-based fashion designer, shocked the fashion world this summer when she announced her Pure Human collection of luxury leather items, to be made from lab-grown human skin, engineered with the late designer Alexander...
by Paul Krzyzanowski | May 25, 2016
A few weeks ago, I came across an interesting story about a stem cell company with a peculiar patenting strategy. As I looked into it further, I realized I’d stumbled into a complicated corporate plot that became more incredible with every turn. Endonovo Therapeutics...
by Paul Krzyzanowski | Dec 16, 2013
> This is part three of an interview series with Michael West, CEO of BioTime. Read parts one and two. The prospects for BioTime and other companies that operate in the tissue engineering and cell therapy market are good. The industry is growing by about 18% per...
by Mark Curtis | Oct 17, 2013
. Welcome to the first Regenerative Medicine Deal Review, an overview of recent licensing, partnering, and financing activity all exclusively in the regenerative medicine and cell therapy industries. Like my first post ‘Update from the Clinic’, this piece is intended...
by Paul Krzyzanowski | Jun 6, 2013
GMO soybeans might have lessons for cell patents. Photo: Philip Dean via Flickr . At first glance, you wouldn’t think that a 76-year old soybean farmer from Indiana would have something in common with microbiologists, but Vernon Hugh Bowman brought back memories of my...
Comments